OFIX

Based on Orthofix Medical Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

What does Orthofix Medical do?

Orthofix Medical is a medical device and biologics company with two segments: Global Spine and Global Orthopedics. It makes bone growth stimulators, spinal implants, regenerative biologics, and orthopedic products for fracture repair and deformity correction. Its customers include surgeons, hospitals, and ambulatory surgery centers across the US and internationally.

Does OFIX pay dividends?

No, Orthofix Medical does not currently pay a dividend. The company retains capital, which is common for small-cap medical device companies investing in product development and commercial infrastructure. Income-focused investors should factor this into their assessment.

When does OFIX report earnings?

Orthofix Medical reports on a quarterly cadence, as is standard for US-listed companies. The company does not pre-announce specific dates far in advance. Check Orthofix Medical's investor relations page for the current earnings calendar and most recent results.

Is OFIX a good stock to buy?

UQS Score rates OFIX as Below Average. The Valuation pillar is Attractive and Growth and Risk are Neutral, but both Quality and Moat are Weak. That combination suggests meaningful fundamental challenges. The full pillar breakdown is available to UQS Pro members for a deeper view.

Is OFIX overvalued?

Based on the UQS Valuation pillar, OFIX is rated Attractive — meaning the market appears to be pricing in a fair degree of risk or uncertainty relative to the company's fundamentals. Whether that discount is warranted depends heavily on execution, which the Weak Quality rating calls into question.

How does OFIX compare to its competitors?

Orthofix competes in the spine and orthopedic device space against a range of medtech companies. Peers like PACB, VREX, and NPCE operate in adjacent but distinct healthcare technology niches. The UQS platform allows side-by-side pillar comparisons — Pro members can view how OFIX stacks up across Quality, Moat, Growth, Risk, and Valuation.

What is OFIX's market cap bracket?

Orthofix Medical is classified as a small-cap company. This places it in a segment of the market that can offer higher growth potential but typically carries greater volatility and liquidity risk compared to large-cap or mega-cap healthcare device peers.

Who founded Orthofix Medical?

Orthofix Medical traces its origins to 1992. The company was formerly known as Orthofix International N.V. before rebranding to Orthofix Medical Inc. in July 2018. Full founding history is publicly available through the company's official filings and investor relations materials.

Is OFIX a long-term quality investment?

As a long-term quality indicator, the UQS Score rates OFIX as Below Average. Weak Quality and Moat pillars are the primary concerns for investors with a long time horizon, as durable returns typically require competitive advantages and consistent business fundamentals. The Attractive Valuation may offer some cushion, but it does not offset structural weaknesses.

What is the main competitive advantage of Orthofix Medical?

The UQS Moat pillar for OFIX is rated Weak, indicating limited durable competitive advantages relative to peers. The company's breadth across spine biologics, bone stimulation, and orthopedic reconstruction provides some product diversification, but this has not translated into a strong moat score under the UQS framework.

What sector does OFIX belong to?

Orthofix Medical operates in the Healthcare sector, specifically within medical devices and biologics. It serves the spine surgery and orthopedic reconstruction markets — areas that intersect with surgical care, hospital procurement, and regulatory oversight by bodies such as the FDA.

Is OFIX a growth stock or value stock?

Based on the UQS profile, OFIX sits in an in-between position. The Growth pillar is Neutral — neither a high-growth story nor a declining one. The Valuation pillar is Attractive, which leans toward value territory. However, the Weak Quality and Moat ratings complicate a straightforward value thesis.

Orthofix Medical Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Orthofix Medical Inc. shows steady but unspectacular growth, typical for mature companies.

Orthofix Medical Inc. maintains a reasonable risk profile with manageable debt levels.

Orthofix Medical Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Orthofix Medical Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for OFIX.

The UQS (Unified Quality Score) for Orthofix Medical Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Orthofix Medical Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Orthofix Medical Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.